PMC:7560789 / 2036-2360 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":260,"end":267},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"The IPA definition used in this paper is based on nondirected BAL GM testing with a cutoff of 1 optical density index, for which sensitivity and specificity are 86% and 95%, respectively, combined with worsening clinical symptoms (i.e., increase in C-reactive protein, worsening PaO2/FiO2 ratio, persistent or rising fever)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T15","span":{"begin":69,"end":76},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T16","span":{"begin":82,"end":83},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"The IPA definition used in this paper is based on nondirected BAL GM testing with a cutoff of 1 optical density index, for which sensitivity and specificity are 86% and 95%, respectively, combined with worsening clinical symptoms (i.e., increase in C-reactive protein, worsening PaO2/FiO2 ratio, persistent or rising fever)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T26","span":{"begin":4,"end":7},"obj":"Chemical"},{"id":"T28","span":{"begin":62,"end":65},"obj":"Chemical"},{"id":"T29","span":{"begin":66,"end":68},"obj":"Chemical"},{"id":"T31","span":{"begin":260,"end":267},"obj":"Chemical"}],"attributes":[{"id":"A26","pred":"chebi_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_17824"},{"id":"A27","pred":"chebi_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_30802"},{"id":"A28","pred":"chebi_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"},{"id":"A29","pred":"chebi_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/CHEBI_74120"},{"id":"A30","pred":"chebi_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/CHEBI_27680"},{"id":"A31","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"The IPA definition used in this paper is based on nondirected BAL GM testing with a cutoff of 1 optical density index, for which sensitivity and specificity are 86% and 95%, respectively, combined with worsening clinical symptoms (i.e., increase in C-reactive protein, worsening PaO2/FiO2 ratio, persistent or rising fever)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T13","span":{"begin":0,"end":324},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The IPA definition used in this paper is based on nondirected BAL GM testing with a cutoff of 1 optical density index, for which sensitivity and specificity are 86% and 95%, respectively, combined with worsening clinical symptoms (i.e., increase in C-reactive protein, worsening PaO2/FiO2 ratio, persistent or rising fever)."}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T3","span":{"begin":66,"end":68},"obj":"GlycoEpitope"}],"attributes":[{"id":"A3","pred":"glyco_epitope_db_id","subj":"T3","obj":"http://www.glycoepitope.jp/epitopes/EP0510"}],"text":"The IPA definition used in this paper is based on nondirected BAL GM testing with a cutoff of 1 optical density index, for which sensitivity and specificity are 86% and 95%, respectively, combined with worsening clinical symptoms (i.e., increase in C-reactive protein, worsening PaO2/FiO2 ratio, persistent or rising fever)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T12","span":{"begin":4,"end":7},"obj":"Phenotype"},{"id":"T13","span":{"begin":317,"end":322},"obj":"Phenotype"}],"attributes":[{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0020103"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0001945"}],"text":"The IPA definition used in this paper is based on nondirected BAL GM testing with a cutoff of 1 optical density index, for which sensitivity and specificity are 86% and 95%, respectively, combined with worsening clinical symptoms (i.e., increase in C-reactive protein, worsening PaO2/FiO2 ratio, persistent or rising fever)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"41","span":{"begin":249,"end":267},"obj":"Gene"},{"id":"76","span":{"begin":317,"end":322},"obj":"Disease"}],"attributes":[{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"Gene:1401"},{"id":"A76","pred":"tao:has_database_id","subj":"76","obj":"MESH:D005334"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The IPA definition used in this paper is based on nondirected BAL GM testing with a cutoff of 1 optical density index, for which sensitivity and specificity are 86% and 95%, respectively, combined with worsening clinical symptoms (i.e., increase in C-reactive protein, worsening PaO2/FiO2 ratio, persistent or rising fever)."}